cagrisema vs semaglutide Updates in Medicine | π¬ REDEFINE 2: in T2D + Obesity Original article link in bio π₯ Phase 3a RCT in 1206 adults with T2D (BMI β₯27, HbA1c 7β10%) π ADA 2025: CagriSema Demonstrates Significant
Description
Can Australians Access Retatrutide Through Clinical Trials
Int J Pharm 662:124504
Doses often need adjusting, blood sugar may need more frequent checking, and you should know the warning signs of hypoglycemia shakiness, sweating, confusion, a racing heart and treat them immediately, fast or no fast
I havent seen much change in lipids on GLP-1s personally
Regulatory Status: advantage goes to Tirzepatide
The molecular weight of the compounds was 438.61 g/mol, 398.68 g/mol, and 488.62 g/mol, respectively
